Ectopic thyroid tissue in thyroglossal duct remnant is related to elevation of serum thyroglobulin after I-131 ablation therapy

被引：0
|
作者：
Jeong, Geum-Cheol [1 ]
Park, Ki Seong [2 ]
Park, Hee Jeong [1 ]
Cho, Sang-Geon [2 ]
Kang, Sae-Ryung [2 ]
Kim, Jahae [2 ]
Kwon, Seong Young [1 ]
Min, Jung-Joon [1 ]
Song, Ho-Chun [2 ]
Bom, Hee-Seung [1 ]
机构：
[1] Chonnam Natl Univ, Hwasun Hosp, Dept Nucl Med, Hwasun Gun, South Korea
[2] Chonnam Natl Univ Hosp, Dept Nucl Med, Gwangju, South Korea
来源：
JOURNAL OF NUCLEAR MEDICINE | 2014年 / 55卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
1952
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Both serum thyroglobulin level after I-131 therapy and pattern of I-131 whole body scan should be considered together for the prediction of excellent response in the patients with differentiated thyroid carcinoma
    Jeong, Geum-Cheol
    Jeon, Su Bin
    Park, Hee Jeong
    Cho, Sang-Geon
    Kang, Sae-Ryung
    Kim, Jahae
    Kwon, Seong Young
    Min, Jung Joon
    Song, Ho-Chun
    Bom, Hee-Seung
    JOURNAL OF NUCLEAR MEDICINE, 2015, 56 (03)
  • [32] Negative serum thyroglobulin in low stage thyroid carcinoma patients with thyroid remnants in the post-ablation therapy I-131 whole body scans: a casuistic analysis
    Macedo, R.
    Correia, J.
    Costa, G.
    Pedroso-Lima, J.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 : S180 - S180
  • [33] Predictive factors for the outcome of I-131 1110MBq ablation therapy in the patients with differentiated thyroid cancer: urinary iodine, serum thyroglobulin, and uptake to thyroid bed
    Ito, S.
    Iwano, S.
    Kato, K.
    Naganawa, S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 : S600 - S601
  • [34] RADIATION-DOSE TO THYROID TISSUE IN I-131 THERAPY OF THYROID ADENOMA
    GORMAN, CA
    ROBERTSON, JS
    JOURNAL OF NUCLEAR MEDICINE, 1977, 18 (06) : 633 - 633
  • [35] Predicting factors of successful postsurgical remnant ablation with I-131 in patients with differentiated thyroid carcinoma
    Fallahi, B.
    Beiki, D.
    Takavar, A.
    Eftekhari, M.
    Fard-Esfahani, A.
    Gilani, K. Ansari
    Saghari, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2010, 37 : S320 - S320
  • [36] Serum thyroglobulin level after radioiodine therapy (Day 3) to predict successful ablation of thyroid remnant in postoperative thyroid cancer
    Kim, Yong-il
    Im, Hyung-Jun
    Paeng, Jin Chul
    Cheon, Gi Jeong
    Kang, Keon Wook
    Lee, Dong Soo
    Park, Do Joon
    Park, Young Joo
    Chung, June-Key
    ANNALS OF NUCLEAR MEDICINE, 2015, 29 (02) : 184 - 189
  • [37] I-131 biokinetics of remnant normal thyroid tissue and residual thyroid cancer in patients with differentiated thyroid cancer
    Kim, Choon-Young
    Son, Seung Hyun
    Jung, Ji-hoon
    Kim, Do-Hoon
    Jeong, Shin Young
    Lee, Sang-Woo
    Lee, Jaetae
    Ahn, Byeong-Cheol
    JOURNAL OF NUCLEAR MEDICINE, 2015, 56 (03)
  • [38] Recombinant TSH or thyroid hormone withdrawal?: A comparison of I-131 remnant ablation rates in thyroid cancer patients
    Luster, M
    Ladenson, P
    Pacini, F
    Schlumberger, M
    Driedger, A
    Kloos, R
    Sherman, S
    Corone, C
    Haugen, B
    Lassmann, M
    Hänscheid, H
    Reiners, C
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2004, 31 : S290 - S291
  • [39] Serum thyroglobulin level after radioiodine therapy (Day 3) to predict successful ablation of thyroid remnant in postoperative thyroid cancer
    Yong-il Kim
    Hyung-Jun Im
    Jin Chul Paeng
    Gi Jeong Cheon
    Keon Wook Kang
    Dong Soo Lee
    Do Joon Park
    Young Joo Park
    June-Key Chung
    Annals of Nuclear Medicine, 2015, 29 : 184 - 189
  • [40] I-131 for Remnant Ablation in Differentiated Thyroid Cancer After Thyroidectomy: A Meta-Analysis of Randomized Controlled Evidence
    Yan Shengguang
    Ji-Eun, Choi
    He Lijuan
    MEDICAL SCIENCE MONITOR, 2016, 22 : 2439 - 2450
12345